Drug intelligence / Profile preview

silybum marianum extract

Development stage
Phase 2
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Silybum marianum extract** refers to extracts derived from the seeds and/or fruits of the Silybum marianum plant (milk thistle). The principal active constituent is **silymarin**, a complex of flavonolignans primarily including silybin (silibinin), silydianin, silychristin, isosilybin, and their associated isomers. Silymarin exhibits **antioxidant**, **anti-inflammatory**, **immunomodulatory**, **antifibrotic**, and **antiproliferative** effects. Its hepatoprotective activity is attributed to free radical scavenging, increasing glutathione content, inhibiting lipid peroxidation, stabilizing cell membranes, and modulating nuclear receptors and cell transporters. Silymarin is known to modulate cytokine signaling (such as TNF-α, IL-2, IL-4, IFN-γ), inhibit apoptosis, and upregulate ribosomal protein synthesis via stimulation of RNA polymerase I. Therapeutic applications primarily include **supportive management of liver disorders** (e.g., cirrhosis, hepatitis, toxin/drug-induced hepatotoxicity), glycemic control in type 2 diabetes, and adjunctive use in mushroom poisoning. The product is considered safe at physiological doses, with rare side effects predominantly gastrointestinal[1][2][3].

Brand names
LivergolSilipideLegalon
Other names
milk thistle extractmilk thistlesilymarin extractsilybum marianum
02

Targets

MAOA (Monoamine oxidase A)NOX4 (NADPH oxidase 4)ER (Estrogen receptor)Pol I (RNA polymerase I)CD3 (T-cell surface glycoprotein CD3)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on silybum marianum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silybum marianum extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call